Poway, CA (PRWEB) September 17, 2013
Over the course of last year, Deuce, a five year old Golden Retriever, was being treated by Dr. Cheryl Adams at Animal Rehabilitation and Wellness Center of Castle Pines for pain that had became so severe that he would require pain medication to get around on most days. Dr. Adams turned to stem cell therapy in April to battle Deuces pain, and just five months since Deuces stem cell therapy his owner, Laura Preston, is happy to report that He has very few sore days, and I have not seen him be stiff or lame in a few months.
Deuce was only four when he started to show signs of discomfort in his back legs. As a Golden Retriever, Deuce can be expected to live an average of 11 active and energetic years, but as a youngster he collided with another dog playing on the beach when he lived in warm San Diego. There were no immediate effects from the accident, but his first winter in cold Colorado brought some issues to owner, Lauras attention.
Deuce was having difficulty getting up from a lying position, walking around the house, or just standing for any length of time. Never mind the fun activities he used to enjoy like long walks in his beautiful home of Castle Rock, Colorado, or enjoying a swim. Dr. Adams and Deuces owners refused to allow him to live with such a decreased quality of life at the young age of five.
Dr. Adams collected a small portion of Deuces fat, which naturally has stem cells in it, and sent it to Vet-Stems lab in San Diego, California. In 48 hours Dr. Adams received a concentrated number of Deuces own stem cells for injection into his hocks. Dr. Adams and Deuces owners hoped stem cells would improve Deuces quality of life by decreasing his pain enough to allow him to stop daily medication and enjoy the activities he used to love so much.
The first few weeks after stem cells he was like a one year old puppy, Laura described, Running and jumping around with no issues. Slowly increasing Deuces movement over time, he was able to return to his full activity level and by three months he had only one noticeably sore day a week. He can run and swim fine, Laura states, All in all he has great improvement!
Deuces veterinarian, Dr. Adams, has been a long-time supporter of stem cell therapy and regenerative medicine in animals. In 2005, Dr. Adams began working with Vet-Stem as a clinical study investigator, and became one of the first credentialed Veterinarians for stem cell treatment. She was involved in the initial small animal clinical studies utilizing autologous, fat derived, stem and regenerative cells to treat orthopedic conditions. She is a published author who in 2007 received an award for Regenerative Stem Cell use in companion animals.
The Animal Rehabilitation and Wellness Center of Castle Pines is proud to be a designated Center of Excellence for Vet-Stem Regenerative Veterinary Medicine, and for their breakthrough work in stem cell therapy. ARWC continues to help with the investigation of the use of stem cell therapy for other diseases such as inflammatory bowel disease (IBS), select neurologic diseases, kidney disease, some liver disease, and atopy (skin allergies), with the goal to achieve optimal wellness and health in companion animals of all ages. ARWC is a referral center committed to helping companion pets recover from illness, injury and surgery.
About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine, visit http://www.vet-stem.com or call 858-748-2004.
See the original post here:
Animal Rehabilitation and Wellness Center Gives Castle Rock Golden Retriever a Second Chance to Enjoy Life with Stem ...
- Cynata looking to revolutionise stem cell therapy - The West Australian - October 28th, 2020
- Exclusive: "Ending Disease" Documentary Explores How Stem Cell Therapy Aims to Cure the Incurable - Prevention.com - October 28th, 2020
- Stem Cell Therapy Industry Market Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast To 2026 - Aerospace Journal - October 28th, 2020
- Study: Poverty Linked to Higher Risk of Death Among Children with Cancer Undergoing Stem Cell Transplantation - PRNewswire - October 28th, 2020
- Global Adipose Derived Stem Cell Therapy Market 2020 Worldwide Industry Analysis, Future Demand and Forecast upto 2025 - re:Jerusalem - October 28th, 2020
- NK Cell Therapy and Stem Cell Therapy Industry Market Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast To 2026 -... - October 28th, 2020
- Stem Cell Therapy Market 2020 In-depth Analysis by Leading Players The Think Curiouser - The Think Curiouser - October 28th, 2020
- Ask Amy: First cancer hits, then heartbreak follows - The Providence Journal - October 28th, 2020
- Ken Shamrock Credits Stem Cell Treatment For Being Able To Wrestle In Impact At 56 - 411mania.com - October 28th, 2020
- Stem Cell Therapy Market: Applications and Regional Insights During the Forecasted Period 2020-2030 - TechnoWeekly - October 28th, 2020
- Robust Growth Of The Animal Stem Cell Therapy Market Predicted Over The Forecast Period 2017 2025 - Aerospace Journal - October 28th, 2020
- Catalent to Produce BrainStorm's NurOwn Cell Therapy for ALS - ALS News Today - October 28th, 2020
- NexImmune Establishes Research Initiative with City of Hope to Focus on Novel Immunotherapeutic Approaches to Acute Myeloid Leukemia - BioSpace - October 28th, 2020
- Stem Cell Therapy Market Highest Growth by 2025 with Leading Players - The Think Curiouser - October 28th, 2020
- Stem Cell Therapy Market to Witness Growth Acceleration During 2020-2025 - Aerospace Journal - October 28th, 2020
- Bayer to pay $2B upfront for AskBio to drive gene therapy expansion - FierceBiotech - October 28th, 2020
- Animal Stem Cell Therapy Market Analysis 2019 Growth by Top Companies and Trends by Types, Treatment, Diagnosis and Application Forecast Analysis to... - October 28th, 2020
- Conventional Chemotherapy May Be Effective in Early-Stage Hodgkin Lymphoma After Relapse - Cancer Therapy Advisor - October 28th, 2020
- SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin - Science - October 21st, 2020
- Stem Cell Therapy Market 2020-2026 | XX% CAGR Projection Over the Next Five Years, Predicts Market Research Future with Market Size & Growth Key... - October 21st, 2020
- While Risky, Sorrento Therapeutics Has Many Options to Win - Investorplace.com - October 21st, 2020
- Stem Cells Offer Hope to Those with Parkinson's Disease - Legal Examiner - October 20th, 2020
- Canine Stem Cell Therapy Market: Know about Impact of Covid-19 by Top Companies like MediVet Biologic, VetStem Biopharma, Stem Cell Vet, Regeneus... - October 20th, 2020
- California Proposition 14: Funding medical research that uses stem cells - KTLA - October 20th, 2020
- Stem Cell Therapy Market Comprehensive Study COVID19 Impact Analysis 2020-2025 - The Think Curiouser - October 20th, 2020
- Stem Cell Therapy Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 - PRnews Leader - October 20th, 2020
- New reports shines light on Cancer Stem Cell Therapy Market Growth strategies adopted by top key players worldwide and assessment to 2026 - PRnews... - October 20th, 2020
- CSL's Broad Response to COVID-19 and Advancements across the Company's Strategic Scientific Platforms are the Focus of Annual R&D; Day - PRNewswire - October 20th, 2020
- Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19) - Eurowire - October 17th, 2020
- Stem Cell Therapy Market Trends, Opportunities, New Technologies and Developments, Competitor analysis and Market Sizing from 2020 to 2026 - PRnews... - October 17th, 2020
- CIRM Bridges to Stem Cell Research & Therapy The Bridge to Everywhere (in biomedicine) OP-ED - The Silicon Valley Voice - October 16th, 2020
- Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD) | DNA RNA and... - October 16th, 2020
- COVID-19 and the trials of treatment | News, Sports, Jobs - Escanaba Daily Press - October 16th, 2020
- UofL-born company secures an additional $115 million to advance cell therapy - uoflnews.com - October 16th, 2020
- Gamida Cell and Be The Match BioTherapies Expand Strategic Collaboration - BioSpace - October 16th, 2020
- Houghton Regis dad appeals for help for life-saving treatment abroad - Dunstable Today - October 16th, 2020
- VERIFY: Was the antibody cocktail used to treat President Trump developed using human embryonic stem cells? - CBS News 8 - October 8th, 2020
- Global Stem Cell Therapy Market 2020 Industry Analysis, Size, Share, Growth, Trend and Forecast to 2025 - re:Jerusalem - October 8th, 2020
- Taking Gene Editing to the Brain, the Immune System, and More - Tufts Now - October 8th, 2020
- Antibody cocktail given to Trump is controversial, and not only because its still under trial - ThePrint - October 7th, 2020
- The Global Stem Cell Therapy Market Growth To 2023 Will Be Driven By Increasing Prevalence Of Chronic Diseases - Press Release - Digital Journal - October 7th, 2020
- Stem cell therapy for blood cancer patients at NIMS - The Hindu - October 7th, 2020
- First Man Cured of AIDS Dies From Cancer - The Keystone Newspaper - October 7th, 2020
- Mesoblast hit by FDA rejection, request to run another trial - FierceBiotech - October 7th, 2020
- FDA Grants Breakthrough Therapy Designation to CD123-Directed Antibody-Drug Conjugate - Targeted Oncology - October 7th, 2020
- Avrobio bags gene therapy to join Regenxbio and Sangamo in race - FierceBiotech - October 7th, 2020
- Global Animal Stem Cell Therapy Market Professional Survey 2020 by Manufacturers, Regions, Types and Applications, Forecast to 2024 - The Daily... - October 4th, 2020
- Stem Cell Therapy Market to Show Incredible Growth by 2025 - The Daily Chronicle - October 4th, 2020
- Coffee enemas and stem cell injections: The life of a biohacker - Wales Online - October 4th, 2020
- EMA starts rapid review of Bluebird's gene therapy for rare disease CALD - - pharmaphorum - October 4th, 2020
- 'Provocative results' boost hopes of antibody treatment for COVID-19 - Science Magazine - October 4th, 2020
- Stem Cell Therapy Market Size, Regional Insights and Global Industry Dynamics By 2027 | By Top Leading Vendors NuVasive, Osiris Therapeutics, JCR... - October 4th, 2020
- Timothy Ray Brown, First Patient to Be Cured of HIV, Dies of Leukemia - BioSpace - October 4th, 2020
- IL-22induced cell extrusion and IL-18induced cell death prevent and cure rotavirus infection - Science - October 4th, 2020
- No on Prop 14: Not the best way to support stem-cell research - Los Angeles Times - October 1st, 2020
- Vitro Biopharma 3rd Quarter ended July 31st 2020 Financial Results of Operations - BioSpace - October 1st, 2020
- Stem cells can repair Parkinson's-damaged circuits in mouse brains - University of Wisconsin-Madison - October 1st, 2020
- Asymmetrex Presents the Value of Tissue Stem Cell Counting For Supplying Stem Cell Clinical Trials and Drug Development Clinical Trials - PR Web - October 1st, 2020
- Smith's 2005 stem cell law to be reauthorized by House - InsiderNJ - October 1st, 2020
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market -Key Players, Size, Growth, Incredible Potential, and Stagnant Progress According to New... - October 1st, 2020
- Risk Based Therapy Approach for Sickle Cell Anemia Patients is Ideal Scenario - MD Magazine - October 1st, 2020
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Analysis by Size, Share, Growth, Application, Segmentation and Forecast to 2025 - The... - October 1st, 2020
- Cytovia Therapeutics to present at Jefferies Cell Therapy Virtual Summit, BIO Investor Forum and New York Stem Cell Foundation Conference in October... - October 1st, 2020
- Timothy Ray Brown, First Person to Be Cured of HIV, Dies - The Scientist - October 1st, 2020
- Global Regenerative Medicine Partnering Report 2014-2020: Access to Cell Therapy, Organ Regeneration, Stem Cells and Tissue Regeneration Partnering... - October 1st, 2020
- UM171 saves another life - Newswise - October 1st, 2020
- Cell Therapy Processing Market COVID 19 Status, Growth Rate by Applications, and Future Forecast 2026 - The Daily Chronicle - October 1st, 2020
- Cell and Gene Therapy Technology Update: ReNeuron Presents Positive Data | Roots Analysis - Crypto Daily - October 1st, 2020
- 20k for treatment to help teenager walk - Southend Standard - September 29th, 2020
- Stem Cell Therapy Market 2020 by Top Key Players, Product Type, End-user Applications, Region and Forecast to 2025 - The Daily Chronicle - September 29th, 2020
- GMP Cell Banking Services Market | Government Bodies Increase Flow of Funding to Discover Treatment Options for Rare Diseases - BioSpace - September 29th, 2020
- The Canine Stem Cell Therapy Market To Go Strong With 4.2% CAGR Between 2026 - Crypto Daily - September 29th, 2020
- Global Cord Blood Banking Market Is Expected to Reach USD 25.90 billion by 2027 : Fior Markets - GlobeNewswire - September 29th, 2020
- Developments In Stem Cell Therapy Market Top Regions, Countries, Sales, Revenue, Leading Companies, Types, Demand, And Forecast Assessment - The Daily... - September 29th, 2020
- Global Stem Cell Therapy for Osteoarthritis Industry 2020 Market Research With Size, Growth, Manufacturers, Segments And 2026 Forecasts Research - The... - September 29th, 2020
- Orchard Therapeutics Receives EMA PRIME Designation for OTL-203 for the Treatment of MPS-I - BioSpace - September 29th, 2020
- Stem Cell Therapy Market Potential Growth, Size, Share, Demand and Analysis of Key Players Research Forecasts to 2027 - The Daily Chronicle - September 29th, 2020
- Dr. Leslie on the Development of CAR T-Cell Therapy in DLBCL and MCL - OncLive - September 29th, 2020
- From artificial lenses to stem cell techniques: these are the most important innovations in ophthalmology - Innovation Origins - September 29th, 2020
- The global market for Nerve Repair and Regeneration is projected to reach US$12.7 billion by 2025 - GlobeNewswire - September 29th, 2020
